SUBSCRIBE
SUBSCRIBE

Sanofi (France)

NEWS
Drug Development
Alnylam Emerges as Winner in Rare Disease Study Showdown With Ionis
Alnylam and Sanofi Genzyme presented positive Phase III results of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy at a conference in France.
November 2, 2017
 · 
3 min read
 · 
Mark Terry
Voyager Sinks as Sanofi Genzyme Opts Out of Parki
Policy
Sanofi Falls Short of Q3 Expectations, Terminates Phase II Lung Drug From Pipeline
Despite Brandicourt’s positive spin, investors were displeased as the company’s financial report fell shy of analysts’ expectations.
November 2, 2017
 · 
2 min read
 · 
Alex Keown
Voyager Sinks as Sanofi Genzyme Opts Out of Parki
Business
Voyager Sinks as Sanofi Genzyme Opts Out of Parkinson’s Gene Therapy Program
Shares of Voyager have fallen more than 12 percent in premarket trading after Sanofi Genzyme walked away from its $845M gene therapy treatment for Parkinson’s disease.
October 31, 2017
 · 
2 min read
 · 
Alex Keown
Deals
Suitors Are Already Lining Up For Sanofi’s $3.51 Billion Generics Biz
October 6, 2017
 · 
1 min read
Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi
Business
Sanofi R&D Boss Thinks His Team is Ready to Survive Without Besties Regeneron and Alnylam
September 21, 2017
 · 
2 min read
Pharm Country
3 Dividend Superstars With Strong Growth Potential: GlaxoSmithKline, Pfizer, Sanofi
September 12, 2017
 · 
1 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
FDA Calls Regeneron, Sanofi Carcinoma Drug a Breakthrough
September 8, 2017
 · 
2 min read
Sanofi’s Zika Standoff: Bad Medicine?
August 11, 2017
 · 
1 min read
Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi
Business
Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi
July 20, 2017
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
December 29, 2025
 · 
5 min read
Press Releases
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
December 24, 2025
 · 
13 min read
Press Releases
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
December 24, 2025
 · 
11 min read
Press Releases
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
December 24, 2025
 · 
9 min read
Press Releases
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
December 23, 2025
 · 
23 min read
Press Releases
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
December 23, 2025
 · 
14 min read
Press Releases
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
December 22, 2025
 · 
7 min read
Press Releases
Press release: Availability of the Q4 2025 Aide memoire
December 17, 2025
 · 
4 min read
Press Releases
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema
December 17, 2025
 · 
6 min read
Press Releases
ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer’s Disease Therapy
December 16, 2025
 · 
2 min read
Load More